Drug shortage
Echothiophate Iodide Ophthalmic Solution · Fera Pharmaceuticals
FDA drug shortage · Current · updated Feb 20, 2025
Key facts
| Generic name | Echothiophate Iodide Ophthalmic Solution |
|---|---|
| Proprietary name | Phospholine Iodide |
| Company | Fera Pharmaceuticals |
| Presentation | Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05) |
| Dosage form | Ophthalmic Solution |
| Strength | 0.125% |
| Status | Current |
| Reason for shortage | Delay in shipping of the drug |
| Therapeutic category | Ophthalmology |
| Package NDCs | 48102-053-05 |
| First posted | Sep 24, 2019 |
| Last updated | Feb 20, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: